The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gromova O.A.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna;
kafedra farmakologii i klinicheskoĭ farmakologii Ivanovskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Torshin I.Iu.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna

Pronin A.V.

Ivanovo State Medical Academy, Ivanovo

Kilchevsky M.A.

Ivanovo State Medical Academy of the RF Ministry of Health, Ivanovo, Russia

Synergistic application of zinc and vitamin C to support memory, attention and the reduction of the risk of the neurological diseases

Authors:

Gromova O.A., Torshin I.Iu., Pronin A.V., Kilchevsky M.A.

More about the authors

Read: 28599 times


To cite this article:

Gromova OA, Torshin IIu, Pronin AV, Kilchevsky MA. Synergistic application of zinc and vitamin C to support memory, attention and the reduction of the risk of the neurological diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(7):112‑119. (In Russ.)
https://doi.org/10.17116/jnevro201711771112-119

Recommended articles:
Non-invasive biomarkers for early diagnosis of Alzheimer’s disease in bodily fluids. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):8-16
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
A comprehensive study of Alzheimer’s disease biomarkers in plasma and cere­brospinal fluid. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):43-53
Prospects for treating Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):54-60
Treatment features of patients with vascular cognitive impairments. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):69-76
Novel prospects for early diagnosis of cognitive impairment using Eye-tracking technology. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):13-20
Cardiogenic deme­ntia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):43-49

References:

  1. Mackenzie GG, Salvador GA, Romero C, Keen CL, Oteiza PI. A deficit in zinc availability can cause alterations in tubulin thiol redox status in cultured neurons and in the developing fetal rat brain. Free Radic Biol Med. 2011;51(2):480-489. https://doi.org/10.1016/j.freeradbiomed.2011.04.028
  2. Torshin IYu, Gromova O.A. Jekspertnyj analiz dannyh v farmakologii. M.: MNCMNO; 2012. (In Russ.).
  3. Rebrov VG, Gromova OA. Vitaminy, makro- i mikrojelementy. M.: GeotarMed; 2008. (In Russ.).
  4. Acuña AI, Esparza M, Kramm C, Beltrán FA, Parra AV, Cepeda C, Toro CA, Vidal RL, Hetz C, Concha II et al. A failure in energy metabolism and antioxidant uptake precede symptoms of huntington’s disease in mice. Nat Commun. 2013;4:2917-2919. https://doi.org/10.1038/ncomms3917
  5. Torshin IYu. Sensing the change from molecular genetics to personalized medicine. Nova Biomedical Books, NY, USA, 2009, In «Bioinformatics in the Post-Genomic Era» series. ISBN 1-60692-217-0
  6. Kulathu Y, Akutsu M, Bremm A, Hofmann K, Komander D. Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain. Nat Struct Mol Biol. 2009;16(12):1328-1330. https://doi.org/10.1038/nsmb.1731
  7. Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell. 2000;5(4):649-658. https://doi.org/10.1016/s1097-2765(00)80244-0
  8. Lopes da Silva S, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, Sijben J, Groenendijk M, Stijnen T. Plasma nutrient status of patients with Alzheimer’s disease: Systematic review and meta-analysis. Alzheimers Dement. 2014;10(4):485-502. https://doi.org/10.1016/j.jalz.2013.05.1771
  9. Swardfager W, Herrmann N, Mazereeuw G, Goldberger K, Harimoto T, Lanctôt KL. Zinc in depression: a meta-analysis. Biol Psychiatry. 2013;74(12):872-878. https://doi.org/10.1016/j.biopsych.2013.05.008
  10. Aquilani R, Baiardi P, Scocchi M, Iadarola P, Verri M, Sessarego P, Boschi F, Pasini E, Pastoris O, Viglio S. Normalization of zinc intake enhances neurological retrieval of patients suffering from ischemic strokes. Nutr Neurosci. 2009;12(5):219-225. https://doi.org/10.1179/147683009X423445
  11. Young B, Ott L, Kasarskis E, Rapp R, Moles K, Dempsey RJ, Tibbs PA, Kryscio R, McClain C. Zinc supplementation is associated with improved neurologic recovery rate and visceral protein levels of patients with severe closed head injury. J Neurotrauma. 1996;13(1):25-34. https://doi.org/ 10.1089/neu.1996.13.25
  12. Mathur NB, Agarwal DK. Zinc Supplementation in Preterm Neonates and Neurological Development, A Randomized Controlled Trial. Indian Pediatr. 2015;52(11):951-955. https://doi.org/ 10.1007/s13312-015-0751-6
  13. Colombo J, Zavaleta N, Kannass KN, Lazarte F, Albornoz C, Kapa LL, Caulfield LE. Zinc supplementation sustained normative neurodevelopment in a randomized, controlled trial of Peruvian infants aged 6—18 months. J Nutr. 2014;144(8):1298-1305. https://doi.org/10.3945/jn.113.189365
  14. Zamora J, Velásquez A, Troncoso L, Barra P, Guajardo K, Castillo-Duran C. Zinc in the therapy of the attention-deficit/hyperactivity disorder in children. A preliminar randomized controlled trial. Arch Latinoam Nutr. 2011;61(3):242-246. https://doi.org/ 10.1186/isrctn03732556
  15. Himmelreich U, Drew KN, Serianni AS, Kuchel PW. 13C NMR studies of vitamin C transport and its redox cycling in human erythrocytes. Biochemistry. 1998;37:7578-7588. https://doi.org/10.1021/bi970765s
  16. Ishikawa T, Casini AF, Nishikimi M. Molecular cloning and functional expression of rat liver glutathione-dependent dehydroascorbate reductase. J Biol Chem. 1998;273:28708-28712. https://doi.org/10.1074/jbc.273.44.28708
  17. Castro MA, Beltrán FA, Brauchi S, Concha II. A metabolic switch in brain: Glucose and lactate metabolism modulation by ascorbic acid. J Neurochem. 2009;110:423-440. https://doi.org/10.1111/j.1471-4159.2009.06151.x
  18. Peterkofsky B. Ascorbate requirement for hydroxylation and secretion of procollagen: Relationship to inhibition of collagen synthesis in scurvy. Am J Clin Nutr. 1991;54:1135-1140. https://doi.org/10.1016/s0174-173x(87)80045-6
  19. Padh H. Cellular functions of ascorbic acid. Biochem Cell Biol. 1990;68:1166-1173. https://doi.org/10.1139/o90-173
  20. Levine M, Wang Y, Rumsey SC. Analysis of ascorbic acid and dehydroascorbic acid in biological samples. Methods Enzymol. 1999;299:65-76. https://doi.org/10.1002/0471140856.tx0706s12
  21. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1996;93:1107-1113. https://doi.org/10.1161/01.cir.93.6.1107
  22. Naseer MI, Ullah N, Ullah I, Koh PO, Lee HY, Park MS, Kim MO. Vitamin C protects against ethanol and PTZ-induced apoptotic neurodegeneration in prenatal rat hippocampal neurons. Synapse. 2011;65:562-571. https://doi.org/10.1002/syn.20875
  23. Santos IM, Tome Ada R, Saldanha GB, Ferreira PM, Militao GC, Freitas RM. Oxidative stress in the hippocampus during experimental seizures can be ameliorated with the antioxidant ascorbic acid. Oxid Med Cell Longev. 2009;2:214-221. https://doi.org/10.4161/oxim.2.4.8876
  24. Qiu S, Li L, Weeber EJ, May JM. Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity. J Neurosci Res. 2007;85:1046-1056. https://doi.org/10.1002/jnr.21204
  25. Ghasemzadeh B, Cammack J, Adams RN. Dynamic changes in extracellular fluid ascorbic acid monitored by in vivo electrochemistry. Brain Res. 1991;547:162-166. https://doi.org/10.1016/0006-8993(91)90587-l
  26. Lee L, Kang SA, Lee HO, Lee BH, Park JS, Kim JH, Jung IK, Park YJ, Lee JE. Relationships between dietary intake and cognitive function level in Korean elderly people. Public Health. 2001;115:133-138. https://doi.org/ 10.1016/s0033-3506(01)00432-2
  27. Ortega RM, Requejo AM, Andres P, Lopez-Sobaler AM, Quintas ME, Redondo MR, Navia B, Rivas T. Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr. 1997;66:803-809. https://doi.org/10.1016/s0033-3506(01)00432-2
  28. Polidori MC, Pratico D, Mangialasche F, Mariani E, Aust O, Anlasik T, Mang N, Pientka L, Stahl W, Sies H, Mecocci P, Nelles G. High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. Journal of Alzheimer’s disease. 2009;17:921-927. https://doi.org/10.3233/jad-2009-1114
  29. McNeill G, Jia X, Whalley LJ, Fox HC, Corley J, Gow AJ, Brett CE, Starr JM, Deary IJ Antioxidant and B vitamin intake in relation to cognitive function in later life in the Lothian birth cohort 1936. Eur J Clin Nutr. 2011;65(5):619-626. https://doi.org/10.1038/ejcn.2011.2
  30. Goodwin JS, Goodwin JM, Garry PJ Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA. 1983;249(21):2917-2921. https://doi.org/ 10.1001/jama.1983.03330450047024
  31. Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ. 1996;312:608-611. https://doi.org/ 10.1136/bmj.312.7031.608
  32. Perrig WJ, Perrig P, Stahelin HB. The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc. 1997;45:718-724. https://doi.org/10.1111/j.1532-5415.1997.tb01476.x
  33. Wengreen HJ, Munger RG, Corcoran CD, Zandi P, Hayden KM, Fotuhi M, Skoog I, Norton MC, Tschanz J, Breitner JC, Welsh-Bohmer KA. Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. J Nutr Health Aging. 2007;11:230-237. https://doi.org/ 10.1016/s0197-4580(04)81561-6
  34. O’Neill RD, Fillenz M, Sundstrom L, Rawlins JN. Voltammetrically monitored brain ascorbate as an index of excitatory amino acid release in the unrestrained rat. Neurosci Lett. 1984;52:227-233. https://doi.org/10.1016/0304-3940(84)90166-6
  35. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging. 2003;24:915-919. https://doi.org/10.1016/s0197-4580(03)00031-9
  36. Fitzgerald KC, O’Reilly EJ, Fondell E, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A. Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: Pooled results from 5 cohort studies. Ann Neurol. 2013;73:236-245. https://doi.org/10.1002/ana.23820
  37. Masaki KH, Losonczy KG, Izmirlian G, Foley DJ, Ross GW, Petrovitch H, Havlik R, White LR. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology. 2000;54:1265-1272. https://doi.org/ 10.1212/wnl.54.6.1265
  38. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Holman A, Witteman JCM, Breteler MMB. Dietary intake of antioxidants and risk of Alzheimer disease. J Am Med Assoc. 2002;287(24):3223-3229. https://doi.org/10.1001/jama.287.24.3223
  39. Neymotin A, Petri S, Calingasan NY, Wille E, Schafer P, Stewart C, Hensley K, Beal MF, Kiaei M. Lenalidomide (revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis. Exp Neurol. 2009;220:191-197. https://doi.org/10.1016/j.expneurol.2009.08.028
  40. Okamoto K, Kihira T, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, Sakamoto N, Inaba Y, Nagai M. Fruit and Vegetable Intake and Risk of Amyotrophic Lateral Sclerosis in Japan. Neuroepidemiology. 2009;32(4):251-256. Epub 2009 Feb 11. https://doi.org/10.1159/000201563
  41. Rebec GV, Pierce RC. A vitamin as neuromodulator: Ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog Neurobiol. 1994;43:537-565. https://doi.org/10.1016/0301-0082(94)90052-3
  42. Dorner JL, Miller BR, Klein EL, Murphy-Nakhnikian A, Andrews RL, Barton SJ, Rebec GV. Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of huntington’s disease. Brain Res. 2009;1290:111-120. https://doi.org/10.1016/j.brainres.2009.07.019
  43. Ide K, Yamada H, Umegaki K, Yokochi T, Harada K. Lymphocyte vitamin C levels as potential biomarker for progression of Parkinson’s disease. Nutrition. Mizuno K, Kawakami N, Hagiwara Y, Matsumoto M, Yoshida H, Kim K, Shiosaki E. 2015;31(2):406-408. https://doi.org/10.1016/j.nut.2014.08.001
  44. Nagayama H, Hamamoto M, Ueda M, Nito C, Yamaguchi H, Katayama Y. The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease. Clin Neuropharmacol. 2004;27:270-273. https://doi.org/10.1097/01.wnf.0000150865.21759.bc

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.